The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Confounding effects of clonal hematopoiesis in clinical genomic profiling of solid tumors.
 
Ahmet Zehir
No Relationships to Disclose
 
Ryan Ptashkin
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Catherine Callaghan Coombs
No Relationships to Disclose
 
Kelly L Bolton
No Relationships to Disclose
 
Zarina Yelskaya
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - ArQule; AstraZeneca; Atara Biotherapeutics; Bayer; Boehringer Ingelheim; Chugai Pharma; CytomX Therapeutics; Debiopharm Group; Genentech; Pfizer
Research Funding - AstraZeneca; Loxo; Puma Biotechnology
 
David B. Solit
Honoraria - Loxo; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - GRAIL; Lilly; Novartis
 
Liying Zhang
No Relationships to Disclose
 
Maria E. Arcila
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Invivoscribe; Raindance Technologies
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - NCCN/AstraZeneca; NCCN/Boehringer Ingelheim
Research Funding - Loxo (Inst)
 
Ross L. Levine
Leadership - Qiagen
Stock and Other Ownership Interests - Loxo
Honoraria - incyte
Consulting or Advisory Role - Novartis
Research Funding - Celgene; Roche
 
Michael F. Berger
Research Funding - Illumina